+1 858-523-8231
Login | Register
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
Home Other Building Blocks 1549812-73-8
1549812-73-8,MFCD30534444
Catalog No.:AA001NFS

1549812-73-8 | Carbamic acid, N-[(3S,4R)-4-hydroxy-3-piperidinyl]-, 1,1-dimethylethyl ester

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
95%
in stock  
$101.00   $71.00
- +
250mg
97%
in stock  
$175.00   $123.00
- +
1g
95%
in stock  
$650.00   $455.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA001NFS
Chemical Name:
Carbamic acid, N-[(3S,4R)-4-hydroxy-3-piperidinyl]-, 1,1-dimethylethyl ester
CAS Number:
1549812-73-8
Molecular Formula:
C10H20N2O3
Molecular Weight:
216.2774
MDL Number:
MFCD30534444
SMILES:
O[C@@H]1CCNC[C@@H]1NC(=O)OC(C)(C)C
Properties
Computed Properties
 
Complexity:
225  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
2  
Heavy Atom Count:
15  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
3  
Rotatable Bond Count:
3  
XLogP3:
0.1  

Downstream Synthesis Route

[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2014/15905,2014,A1

[2]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-US2015/175600,2015,A1

[3]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2016/185279,2016,A1

[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2014/15905,2014,A1

[2]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-US2015/175600,2015,A1

[3]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2016/185279,2016,A1

(trans)-benzyl3-((tert-butoxycarbonyl)amino)-4-hydroxypiperidine-1-carboxylate 
  1549812-73-8 

[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2014/15905,2014,A1

[2]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2016/185279,2016,A1

cis-benzyl4-(benzoyloxy)-3-((tert-butoxycarbonyl)amino)piperidine-1-carboxylate 
  1549812-73-8 

[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2014/15905,2014,A1

[2]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2016/185279,2016,A1

[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2014/15905,2014,A1Locationinpatent:Page/Pagecolumn61;62

[2]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-US2015/175600,2015,A1Locationinpatent:Paragraph0469;0470;0471

[3]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2016/185279,2016,A1Locationinpatent:Page/Pagecolumn103

Literature

Title: Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation.

Journal: Nature chemical biology 20150301

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 1549812-73-8
1000576-83-9

1000576-83-9

 1169762-18-8

1169762-18-8

 1227917-63-6

1227917-63-6

 1251017-66-9

1251017-66-9

 1196147-27-9

1196147-27-9

 1270019-92-5

1270019-92-5
Building Blocks
More >
Tags:1549812-73-8 Molecular Formula|1549812-73-8 MDL|1549812-73-8 SMILES|1549812-73-8 Carbamic acid, N-[(3S,4R)-4-hydroxy-3-piperidinyl]-, 1,1-dimethylethyl ester